N,N-bis(pyridin-2-ylmethyl)-1-[2-[3-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl)phenyl]phenyl]methanamine
C36H47N7 — CID 155560382
Data last refreshed: (MolForge compound catalog, from PubChem)
About N,N-bis(pyridin-2-ylmethyl)-1-[2-[3-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl)phenyl]phenyl]methanamine
N,N-bis(pyridin-2-ylmethyl)-1-[2-[3-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl)phenyl]phenyl]methanamine (PubChem CID 155560382) has the molecular formula C36H47N7 and a molecular weight of 577.82 g/mol. Its IUPAC name is N,N-bis(pyridin-2-ylmethyl)-1-[2-[3-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl)phenyl]phenyl]methanamine.
Molecular Properties
| Compound Name | N,N-bis(pyridin-2-ylmethyl)-1-[2-[3-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl)phenyl]phenyl]methanamine |
|---|---|
| PubChem CID | 155560382 |
| Molecular Formula | C36H47N7 |
| Molecular Weight | 577.82 g/mol |
| Exact Mass | 577.39 |
| IUPAC Name | N,N-bis(pyridin-2-ylmethyl)-1-[2-[3-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl)phenyl]phenyl]methanamine |
| SMILES | c1ccc(CN(Cc2ccccn2)Cc2ccccc2-c2cccc(CN3CCCNCCNCCCNCC3)c2)nc1 |
| InChI | InChI=1S/C36H47N7/c1-2-15-36(33(11-1)28-43(29-34-13-3-5-19-40-34)30-35-14-4-6-20-41-35)32-12-7-10-31(26-32)27-42-24-9-18-38-22-21-37-16-8-17-39-23-25-42/h1-7,10-15,19-20,26,37-39H,8-9,16-18,21-25,27-30H2 |
| InChIKey | PTRXOULFRUBYQN-UHFFFAOYSA-N |
| XLogP | 4.71 |
| TPSA | 68.35 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 43 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 577.82 |
| LogP ≤ 5 | 4.71 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155560382 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.